Several preclinical studies have shown that neoadjuvant PD-1/PD-L1 blockade disrupts immunodominance and facilitates the early establishment of immunological memory following primary tumor resection, a phenomenon not observed in the adjuvant setting [204, 205]. This evidence concerns the gene CD274 and neoplasm.